120 related articles for article (PubMed ID: 14960327)
1. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.
Petros AM; Gunasekera A; Xu N; Olejniczak ET; Fesik SW
FEBS Lett; 2004 Feb; 559(1-3):171-4. PubMed ID: 14960327
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
Xu H; Tai J; Ye H; Kang CB; Yoon HS
Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
[TBL] [Abstract][Full Text] [Related]
3. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
Petros AM; Nettesheim DG; Wang Y; Olejniczak ET; Meadows RP; Mack J; Swift K; Matayoshi ED; Zhang H; Thompson CB; Fesik SW
Protein Sci; 2000 Dec; 9(12):2528-34. PubMed ID: 11206074
[TBL] [Abstract][Full Text] [Related]
4. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR
Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330
[TBL] [Abstract][Full Text] [Related]
5. NMR studies of the interaction between human programmed cell death 5 and human p53.
Yao H; Feng Y; Zhou T; Wang J; Wang ZX
Biochemistry; 2012 Apr; 51(13):2684-93. PubMed ID: 22372375
[TBL] [Abstract][Full Text] [Related]
6. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
7. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
8. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif.
Xu H; Ye H; Osman NE; Sadler K; Won EY; Chi SW; Yoon HS
Biochemistry; 2009 Dec; 48(51):12159-68. PubMed ID: 19916559
[TBL] [Abstract][Full Text] [Related]
9. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
11. Latent and active p53 are identical in conformation.
Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
[TBL] [Abstract][Full Text] [Related]
12. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
Denisov AY; Chen G; Sprules T; Moldoveanu T; Beauparlant P; Gehring K
Biochemistry; 2006 Feb; 45(7):2250-6. PubMed ID: 16475813
[TBL] [Abstract][Full Text] [Related]
13. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
[TBL] [Abstract][Full Text] [Related]
14. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.
Moll UM; Marchenko N; Zhang XK
Oncogene; 2006 Aug; 25(34):4725-43. PubMed ID: 16892086
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed pro- and anti-apoptogenic genes in response to benzene exposure: Immunohistochemical localization of p53, Bag, Bad, Bax, Bcl-2, and Bcl-w in lung epithelia.
Weaver CV; Liu SP
Exp Toxicol Pathol; 2008 Mar; 59(5):265-72. PubMed ID: 18093815
[TBL] [Abstract][Full Text] [Related]
17. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
18. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia.
Endo H; Saito A; Chan PH
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1283-6. PubMed ID: 17073802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
